Document is current
Any future updates will be listed below
-
Authors
Chew, Emily Y. https://orcid.org/0000-0003-0999-9802
Burns, Stephen A. https://orcid.org/0000-0001-5348-035X
Abraham, Alison G.
Bakhoum, Mathieu F.
Beckman, Joshua A.
Chui, Toco Y. P.
Finger, Robert P.
Frangi, Alejandro F. https://orcid.org/0000-0002-2675-528X
Gottesman, Rebecca F. https://orcid.org/0000-0002-9504-1256
Grant, Maria B.
Hanssen, Henner https://orcid.org/0000-0001-5501-4205
Lee, Cecilia S.
Meyer, Michelle L.
Rizzoni, Damiano
Rudnicka, Alicja R.
Schuman, Joel S. https://orcid.org/0000-0002-8885-3766
Seidelmann, Sara B.
Tang, W. H. Wilson https://orcid.org/0000-0002-8335-735X
Adhikari, Bishow B.
Danthi, Narasimhan https://orcid.org/0000-0002-3018-2330
Hong, Yuling
Reid, Diane
Shen, Grace L.
Oh, Young S.
- License Information
-
More Information
Article History
Accepted: 21 June 2024
First Online: 22 July 2024
Competing interests
: The views expressed in this article are those of the authors and do not necessarily represent the views of the National Eye Institute; the National Heart, Lung, and Blood Institute; the NIH; or the US Department of Health and Human Services. This work was supported by the intramural programme funds of the National Eye Institute (E.Y.C.). No industry support was used for this project. J.A.B. declares consulting for Jan One, Janssen and Novartis. J.S.S. declares having served as consultant for Alcon Laboratories, Boehringer Ingelheim, Dompe and Regeneron Pharmaceutical; having served as consultant and having received grant support from Bright Focus Foundation, National Eye Institute and Perfuse; having served as consultant and being a stockholder for AEYE Heath, Ocugenex, Ocular Therapeutix, Opticient and Tarus; having served as a consultant and having received royalties from Carl Zeiss Meditec, New York University School of Medicine, SLACKS, Tufts University School of Medicine and University of Pittsburgh Medical Center. W.H.W.T. has served as a consultant for Boston Scientific, CardiaTec Biosciences, Cardiol Therapeutics, Genomics, Intellia Therapeutics, Kiniksa Pharmaceuticals, Renovacor, Sequana Medical, WhiteSwell and Zehna Therapeutics, and has received honoraria from the American Board of Internal Medicine, Belvoir Media Group and Springer. The other authors declare no competing interests.
